Toggle navigation
Home
Search
Services
Blog
Contact
About
DNA Probes for Detection of Chromosomal Translocations
Foulkes, Gordon
Osi Pharmaceuticals, Inc., Uniondale, NY, United States
Search 3 grants from Gordon Foulkes
Search grants from Osi Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
Longitudinal Changes in Recovery from Drug Use Disorders: A National Study
Chronoendocrinology of Sleep Disturbances in Depression
Evaluation of Topical 24-EPI-1,25-Dihydroxyvitamin D2
Membrane-Microfilament Connections
Recently added grants:
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria
Mechanistic analysis and allellic genome editing of iPSC-derived dominant LCA model
Extracellular Vesicle Analyses to Develop Aging and Resilience Biomarkers
Diverse Homeostatic Roles for Distinct Macrophages in the Developing Lung Vasculature
Protein Kinase Novel 2 (PKN2) in heart
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA040868-03
Application #
3506466
Study Section
(SSS)
Project Start
1985-07-01
Project End
1989-05-31
Budget Start
1988-06-01
Budget End
1989-05-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Institution
Name
Osi Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Uniondale
State
NY
Country
United States
Zip Code
11553
Related projects
NIH 1988
R44 CA
DNA Probes for Detection of Chromosomal Translocations
Foulkes, Gordon / Osi Pharmaceuticals, Inc.
NIH 1987
R44 CA
DNA Probes for Detection of Chromosomal Translocations
Gordon, Foulkes / Osi Pharmaceuticals, Inc.
Comments
Be the first to comment on Gordon Foulkes's grant